The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders.

This publication has 30 references indexed in Scilit:

• A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease
  American Heart Journal, 1999
• EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHECK PLUS® IN VARIOUS CLINICAL SETTINGS
  Thrombosis Research, 1997
• Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor
  Critical Care Medicine, 1995
• Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor
  The Journal of Pediatrics, 1995
• Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experience
  American Heart Journal, 1994
• Bedside monitoring of heparin therapy: comparison of activated clotting time to activated partial thromboplastin time
  Catheterization and Cardiovascular Diagnosis, 1994
• On-site Prothrombin Time, Activated Partial Thromboplastin Time, and Platelet Count A Comparison between Whole Blood and Laboratory Assays with Coagulation Factor Analysis in Patients Presenting for Cardiac Surgery
  Anesthesiology, 1994
• Outpatient Use of a Portable International Normalized Ratio/Prothrombin Time Monitor
  Southern Medical Journal, 1994
• Comparison of Bedside Coagulation Monitoring Tests with Standard Laboratory Tests in Patients After Cardiac Surgery
  Anesthesia & Analgesia, 1993
• Validation of a bedside method of activated partial thromboplastin time measurement with clinical range guidelines
  The American Journal of Cardiology, 1991